HealthDay - MONDAY, June 29 (HealthDay News) — The immunosuppressive drug
golimumab shows promise in treating rheumatoid arthritis patients who
don’t respond to other drugs, according to a new study. Golimumab is from
the family of drugs called tumor necrosis factor-a (TNF-a) inhibitors.